Shanghai Rightongene Biotechnology Co., Ltd.

¥20.97As of Sun 8 Nov 2026, 12:00 UTC
SSE:688217Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (28.05%)
Div yield —
ROE (8.84%)
Biotechnology
Beta (5Y) 0.63
PE TTM —
TSR TTM (28.18%)
Mkt cap ¥1.157B
ROIC (5.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥24
12.43%
(48.67%)
Hold 9|4|10|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.26
0.26
0.25
0.27
21.07%
9.43%
7.06%
12.79%
Revenue¥M
113.8
115.7
117.4
123.5
5.95%
8.60%
5.66%
10.27%
Peers (US$173.5M)
Cap (US$)
PE
173.9M
—
170.4M
—
168.3M
—
171.1M
—
Capital
TTM
5Y
10Y
Leveragex
3.674
0.055
0.052
EBIT/Intx
2.996
0.452
0.321
Own earn%
(53.45)
(15.77)
(18.58)
Sh yield%
35.77
15.74
13.21
Owners
Insiders/Inst%
2.68
88.04
Short interest%
5.26
SBC / revenue%
5.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
10–21
$1 testx
—
Incr. ROIC%
87